A proposal for the economic revitalization minister to double as vaccination chief is being floated, with Japan aiming to decide on a new appointment by the end of March, according to sources familiar with the situation.
A Japanese health ministry panel approves the administration of Pfizer Inc. s coronavirus vaccine to children aged 5 to 11, making it the first in Japan to be available for the age group.
A Japanese health ministry panel approves the administration of U.S. biotechnology firm Moderna Inc. s COVID-19 booster shots at least six months after an individual aged 18 or older has received their second dose.
Japanese biotech firm Takara Bio Inc. will start producing messenger RNA vaccines on a contract basis possibly from next January, its officials say, in a move likely to help cut the country s reliance on imports for COVID-19 vaccines.
The Gunma prefectural government says that foreign substances were discovered in Moderna Inc. s COVID-19 vaccine, the latest in a series of contaminants in the company s product reported in Japan over the past several days.